Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen cash paid for interest, net ($M) ($M)
Form 10-Q / 10-K (DB)
Latest, FY2025
2,900
Period ended Dec 31, 2025
Change on a year earlier
-12.1%
3,300 in FY2024
History
18 years
Since FY2008
Sources
14
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash paid for interest, net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,900 | -12.1% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 3,300 | +37.5% | Form 10-K (filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | 2,400 | +100.0% | Form 10-K (filed 2024-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 1,200 | 0.0% | Form 10-K (filed 2023-02-09) ↗ |
| FY2021 | Dec 31, 2021 | 1,200 | 0.0% | Form 10-K (filed 2022-02-16) ↗ |
| FY2020 | Dec 31, 2020 | 1,200 | -7.7% | Form 10-K (filed 2021-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 1,300 | -13.3% | Form 10-K (filed 2020-02-12) ↗ |
| FY2018 | Dec 31, 2018 | 1,500 | +15.4% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 1,300 | +8.3% | Form 10-K (filed 2018-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 1,200 | +20.0% | Form 10-K (filed 2017-02-14) ↗ |
| FY2015 | Dec 31, 2015 | 1,000 | -9.1% | Form 10-K (filed 2016-02-16) ↗ |
| FY2014 | Dec 31, 2014 | 1,100 | 0.0% | Form 10-K (filed 2016-02-16) ↗ |
| FY2013 | Dec 31, 2013 | 1,100 | +128.7% | Form 10-K (filed 2016-02-16) ↗ |
| FY2012 | Dec 31, 2012 | 481 | +7.8% | Form 10-K (filed 2015-02-19) ↗ |
| FY2011 | Dec 31, 2011 | 446 | +38.1% | Form 10-K (filed 2012-02-29) ↗ |
| FY2010 | Dec 31, 2010 | 323 | +10.2% | Form 10-K (filed 2011-02-25) ↗ |
| FY2009 | Dec 31, 2009 | 293 | -3.3% | Form 10-K (filed 2011-02-25) ↗ |
| FY2008 | Dec 31, 2008 | 303 | – | Form 10-K (filed 2011-02-25) ↗ |
Cite this data
StockData. (2026). Amgen Cash paid for interest, net ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_int_paid
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.